Magnetic Resonance Imaging and Manganism: A Narrative Review and Laboratory Recommendations.
Michal MajewskiKarolina PiwkoMichal OrdakElzbieta MuszynskaTadeusz NasierowskiMagdalena Bujalska-ZadroznyPublished in: Journal of clinical medicine (2024)
In recent years, a series of articles has been published concerning magnetic resonance imaging (MRI) studies in a group of patients exposed to manganism, specifically factory workers, welders, and individuals with liver diseases, as well as those abusing home-produced ephedrone. Some potential symptoms of manganese toxicity include motor disturbances, neurocognitive problems, sleep disorders, and psychosocial changes. Despite various publications on MRI research in individuals with an elevated risk of manganism, there is a noticeable absence of a comprehensive review in this field. The detection of the accumulation of manganese in the brain through MRI can confirm the diagnosis and guide appropriate treatment. Due to the high cost of determining manganese ion levels in biological material, an additional aim of the manuscript was to identify simple medical laboratory parameters that, when performed concurrently with MRI, could assist in the diagnosis of manganism. Among these types of parameters are the levels of bilirubin, magnesium, liver enzymes, creatinine, hemoglobin, and hematocrit.
Keyphrases
- magnetic resonance imaging
- contrast enhanced
- diffusion weighted imaging
- computed tomography
- end stage renal disease
- mental health
- healthcare
- magnetic resonance
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- sleep quality
- prognostic factors
- blood brain barrier
- depressive symptoms
- risk assessment
- randomized controlled trial
- oxidative stress
- bipolar disorder
- brain injury
- replacement therapy
- human health
- resting state
- smoking cessation